Your browser doesn't support javascript.
loading
Induction of p53-mediated senescence is essential for the eventual anticancer therapeutic effect of RH1.
Jung, Joohee; Song, Do Young; Hwang, Jung Jin; Park, Heon Joo; Lee, Jung Shin; Song, Si Yeol; Jeong, Seong-Yun; Choi, Eun Kyung.
Afiliação
  • Jung J; College of Pharmacy, Duksung Women's University, Seoul, 01369, Korea.
  • Song DY; Innovative Drug Center, Duksung Women's University, Seoul, 01369, Korea.
  • Hwang JJ; Institute for Innovative Cancer Research, Asan Medical Center, Seoul, 05505, Korea.
  • Park HJ; Asan Institute for Life Sciences, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, 05505, Korea.
  • Lee JS; Institute for Innovative Cancer Research, Asan Medical Center, Seoul, 05505, Korea.
  • Song SY; Asan Institute for Life Sciences, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, 05505, Korea.
  • Jeong SY; Department of Convergence Medicine, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, 05505, Korea.
  • Choi EK; Center for Advancing Cancer Therapeutics, ASAN Medical Center, Seoul, 05505, Korea.
Arch Pharm Res ; 42(9): 815-823, 2019 Sep.
Article em En | MEDLINE | ID: mdl-30879173

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aziridinas / Benzoquinonas / Proteína Supressora de Tumor p53 / Senescência Celular / Antineoplásicos Limite: Humans Idioma: En Revista: Arch Pharm Res Ano de publicação: 2019 Tipo de documento: Article País de publicação:

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aziridinas / Benzoquinonas / Proteína Supressora de Tumor p53 / Senescência Celular / Antineoplásicos Limite: Humans Idioma: En Revista: Arch Pharm Res Ano de publicação: 2019 Tipo de documento: Article País de publicação: